# Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia

> **NCT01182662** · PHASE2 · UNKNOWN · sponsor: **Shandong University** · enrollment: 30 (estimated)

## Conditions studied

- Aplastic Anemia

## Interventions

- **OTHER:** Human umbilical cord-derived MSCs and cyclosporin A
- **OTHER:** cyclosporin A

## Key facts

- **NCT ID:** NCT01182662
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01182662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01182662, "Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01182662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*